Ledger.Open graph →

SEC Form D · Amendment · filed March 31, 2021

STAQ Pharma, Inc

Offering

$9.0M

Sold

$9.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

DENVER, CO

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Joseph W. Bagan · Denver, COExec · Director Chet M. Kaczor · DENVER, CODirector Jerrod M. Milton · DENVER, CODirector Mark M. Spiecker · DENVER, COExec · Director Jeffrey L. Hval · DENVER, COExec · Director Stephen M. Davis · DENVER, CODirector Donna M. Lynne · DENVER, CODirector Dan M. Seff · DENVER, CODirector Steven M. Summer · DENVER, CODirector Akash J. Bakshi · Boston, MADirector Michael J. Salsbury · Boston, MADirector Richard J. Kang · Boston, MADirector George J. Quinoy · San Diego, CADirector Stephen E. Ryan · San Diego, CAExec · Director Amar U. Shah · Chicago, ILExec · Director Aurelio E. Fernandez · San Diego, CAExec · Director Mark M. Clements · Chicago, ILDirector David M. Reyna · Chicago, ILDirector Stephen Luongo · Chicago, ILExec · Director Matthew Schaefer · Chicago, ILDirector Philip Lee · New York, NYDirector Donald Mullen · New York, NYDirector Jonathan Ezrow · New York, NYExec · Director Bruno Mota · Porto, S1Exec · Director Kyle Petrelli · Hoboken, NJDirector Carla R. York · HENAGER, ALDirector Catherine R. Baucom · BATON ROUGE, LADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗